Miller LH - Search Results

1

Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.

Miura K, Zhou H, Diouf A, Moretz SE, Fay MP, Miller LH, Martin LB, Pierce MA, Ellis RD, Mullen GE, Long CA. Miura K, et al. Among authors: miller lh. Clin Vaccine Immunol. 2009 Jul;16(7):963-8. doi: 10.1128/CVI.00042-09. Epub 2009 May 13. Clin Vaccine Immunol. 2009. PMID: 19439523 Free PMC article.

2

A merozoite receptor protein from Plasmodium knowlesi is highly conserved and distributed throughout Plasmodium.

Waters AP, Thomas AW, Deans JA, Mitchell GH, Hudson DE, Miller LH, McCutchan TF, Cohen S. Waters AP, et al. Among authors: miller lh. J Biol Chem. 1990 Oct 15;265(29):17974-9. J Biol Chem. 1990. PMID: 2211675 Free article.

3

The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.

Quakyi IA, Carter R, Rener J, Kumar N, Good MF, Miller LH. Quakyi IA, et al. Among authors: miller lh. J Immunol. 1987 Dec 15;139(12):4213-7. J Immunol. 1987. PMID: 2447164

4

Involvement of T cells in malaria immunity: implications for vaccine development.

Good MF, Miller LH. Good MF, et al. Among authors: miller lh. Vaccine. 1989 Feb;7(1):3-9. doi: 10.1016/0264-410x(89)90002-9. Vaccine. 1989. PMID: 2655342 Review.

5

A 60-kDa Plasmodium falciparum protein at the moving junction formed between merozoite and erythrocyte during invasion.

Klotz FW, Hadley TJ, Aikawa M, Leech J, Howard RJ, Miller LH. Klotz FW, et al. Among authors: miller lh. Mol Biochem Parasitol. 1989 Sep;36(2):177-85. doi: 10.1016/0166-6851(89)90190-4. Mol Biochem Parasitol. 1989. PMID: 2671726

6

The main obstacle to a malaria vaccine: the malaria parasite.

Miller LH, Good MF. Miller LH, et al. Vaccine. 1988 Apr;6(2):104-6. doi: 10.1016/s0264-410x(88)80008-2. Vaccine. 1988. PMID: 3291447 Review.

7

Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1).

Miller LH, Roberts T, Shahabuddin M, McCutchan TF. Miller LH, et al. Mol Biochem Parasitol. 1993 May;59(1):1-14. doi: 10.1016/0166-6851(93)90002-f. Mol Biochem Parasitol. 1993. PMID: 8515771

8

Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.

Kumar S, Yadava A, Keister DB, Tian JH, Ohl M, Perdue-Greenfield KA, Miller LH, Kaslow DC. Kumar S, et al. Among authors: miller lh. Mol Med. 1995 Mar;1(3):325-32. Mol Med. 1995. PMID: 8529111 Free PMC article.

9

Genetic regulation of protective immune response in congenic strains of mice vaccinated with a subunit malaria vaccine.

Tian JH, Miller LH, Kaslow DC, Ahlers J, Good MF, Alling DW, Berzofsky JA, Kumar S. Tian JH, et al. Among authors: miller lh. J Immunol. 1996 Aug 1;157(3):1176-83. J Immunol. 1996. PMID: 8757623

10

Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.

Tian JH, Kumar S, Kaslow DC, Miller LH. Tian JH, et al. Among authors: miller lh. Infect Immun. 1997 Aug;65(8):3032-6. doi: 10.1128/iai.65.8.3032-3036.1997. Infect Immun. 1997. PMID: 9234750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

532 results

Search Page

Filters